HUONS CO., LTD. Logo

HUONS CO., LTD.

Develops and manufactures pharmaceuticals, medical solutions, and medical devices.

243070 | KO

Overview

Corporate Details

ISIN(s):
KR7243070000
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 창업로 17 판교 아이스퀘어 A동 8층, 성남시

Description

HUONS CO., LTD. is an integrated pharmaceutical and healthcare company founded in 1965. The company develops and manufactures a wide range of finished pharmaceutical products, medical solutions, and medical devices under cGMP standards. It was a pioneer in its domestic market, developing the first plastic ampule injections and local anesthetics. The company's research and development efforts focus on key therapeutic areas including ophthalmology, osteoarthritis, dermatology, wellness, and Central Nervous System (CNS) disorders. Its diversified portfolio also extends to bio products, eye drops, cosmetics, and health functional foods, aiming to provide comprehensive healthcare solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-02-26 00:00
[기재정정]신규시설투자등
Korean 10.2 KB
2024-02-14 00:00
공정거래자율준수프로그램운영현황
Korean 22.6 KB
2024-02-14 00:00
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 5.8 KB
2024-02-14 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 18.0 KB
2024-02-14 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.8 KB
2024-02-14 00:00
현금ㆍ현물배당결정
Korean 9.5 KB
2024-02-14 00:00
연결재무제표기준영업실적등에대한전망(공정공시)
Korean 10.9 KB
2024-01-30 00:00
결산실적공시예고
Korean 4.5 KB
2024-01-30 00:00
기업설명회(IR)개최
Korean 6.7 KB
2024-01-30 00:00
기업설명회(IR)개최
Korean 6.8 KB
2024-01-05 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.2 KB
2024-01-05 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.2 KB
2024-01-05 00:00
투자판단관련주요경영사항(임상시험계획승인신청등결정)(HUC1-394(NCP112 점안제)의 제 1상 임상시험의 한국 임상시험계획(IND) 승인)
Korean 10.8 KB
2023-12-22 00:00
타인에대한담보제공결정
Korean 19.6 KB
2023-12-14 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB

Automate Your Workflow. Get a real-time feed of all HUONS CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HUONS CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HUONS CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.